LIA (Group I) (Mean ± SD) | ACB (Group II) (Mean ± SD) | ACB AND LIA (Group III) (Mean ± SD) | p-value | |||
---|---|---|---|---|---|---|
Group (I vs. II) | Group (I vs. III) | Group (II vs. III) | ||||
Age (Years) | 65.7 ± 10 | 67.2 ± 8 | 68.2 ± 8.3 | 0.743 | 0.431 | 0.868 |
Flexion of knee on 1st POD | 78.3 ± 6.4 | 77 ± 7.6 | 80.3 ± 4.2 | 0.641 | 0.324 | 0.054 |
Pain Score | ||||||
0 HR | 2 ± 0.7 | 2.3 ± 1.5 | 1.8 ± 1 | 0.523 | 0.709 | 0.149 |
6 HR | 2.8 ± 1.2 | 2.8 ± 1.2 | 2.3 ± 1.3 | 1.000 | 0.166 | 0.166 |
12 HR | 2.5 ± 1.2 | 3 ± 1.1 | 2.4 ± 1 | 0.078 | 0.873 | 0.023* |
24 HR | 2.7 ± 1.1 | 3.4 ± 1 | 2.6 ± 1.2 | 0.018* | 0.866 | 0.004* |
Change (0 to 24 h) | 0.70 ± .12 | 1.1 ± 1.69 | 0.77 ± 1.44 | |||
p–value of Change | 0.001* | 0.0001* | 0.002* | |||
Consumption of Fentanyl | ||||||
0–6 HR | 6 ± 4.1 | 7.4 ± 5.6 | 3.5 ± 3.8 | 0.360 | 0.042* | 0.001* |
6–12 HR | 8.1 ± 6.1 | 10.6 ± 7.1 | 5.7 ± 4.8 | 0.172 | 0.179 | 0.001* |
12–24 HR | 9.2 ± 6.7 | 11 ± 6.3 | 6.6 ± 5.5 | 0.367 | 0.160 | 0.005* |
Change (0–6 to 12–24 h) | 3.20 ± 5.99 | 3.67 ± 5.82 | 3.15 ± 5.17 | |||
p–value of Change | 0.002* | 0.0001* | 0.0001* | |||
WOMAC Score | ||||||
Pre-operative | 61.7 ± 6.6 | 62.9 ± 8.1 | 61.5 ± 10.1 | 0.799 | 0.998 | 0.761 |
2 Weeks follow up | 55.2 ± 6.4 | 55.9 ± 7.8 | 55 ± 9.5 | 0.919 | 0.989 | 0.856 |
6 weeks follow up | 27.7 ± 5.2 | 27.3 ± 5.8 | 29 ± 6.6 | 0.950 | 0.574 | 0.392 |
Change (Pre Op to 6 weeks) | 33.97 ± 4.45 | 35.57 ± 4.81 | 32.52 ± 5.13 | |||
p–value of Change | 0.0001* | 0.0001* | 0.0001* |